TNFSF10 and ovarian cancer: Most of the 44 ovarian cancer ascites (82%) led to some degree of inhibition of TRAIL-induced apoptosis as demonstrated by an increase of TRAIL IC50 with ascites > 1.25 fold while the few remaining did not affect the TRAIL sensitivity of CaOV3 cells (neutral effect).